Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Helix BioPharma Corp. (T.HBP) had Operating Cash Flow per Share of -0.01 for the most recently reported fiscal quarter, ending 2025-10-31.
| Income Statement Financials | |
-- |
|
-0.73M |
|
-- |
|
-- |
|
-- |
|
-0.67M |
|
-- |
|
-0.73M |
|
-0.73M |
|
-0.73M |
|
-0.73M |
|
-0.73M |
|
-0.73M |
|
-0.68M |
|
-0.68M |
|
75.87M |
|
75.87M |
|
-0.01 |
|
-0.01 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
13.74M |
|
-- |
|
-- |
|
-- |
|
2.16M |
|
11.58M |
|
-1.67M |
|
11.58M |
|
76.38M |
|
| Cash Flow Statement Financials | |
-0.88M |
|
-- |
|
1.19M |
|
0.05M |
|
0.36M |
|
0.31M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.23 |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-0.88M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-6.27% |
|
43.39% |
|
-5.29% |
|
-6.27% |
|
0.21 |
|
-0.01 |
|
|
Operating Cash Flow per Share |
-0.01 |